Wu Tsai Human Performance Alliance
Showing 301-320 of 381 Results
-
Kevin Shea
Chambers-Okamura Endowed Professor of Pediatric Orthopaedics
BioKevin G. Shea, MD is at Stanford University. He grew up in Montana and California, graduated from the University of Notre Dame, UCLA School of Medicine, and completed his orthopaedic residency at the University of Utah. His advanced training includes pediatric orthopaedics at Rady Children’s Hospital in San Diego, AO Fellowship in Bern Switzerland with Dr. Ganz (Hip), Dr. Diego Fernandez (Trauma), and Dr. Hans Staubli (sports), Ilizarov Training in Lecco, Italy. He has done the AOSSM South American Traveling Sports Medicine Fellowship, and education in Russia and former Soviet Bloc countries. Most of his early career was in Boise, Idaho.
Dr. Shea is a founding member of the PRISM Society (Pediatric Research in Sports Medicine) and the ROCK (Research in Osteochondritis Dissecans of the Knee) Multi-center Study Group, and the SCORE (Sports Cohort Outcomes Research ) Multi-Center Registry for pediatric sports. He has authored more than 300 scientific papers and chapters. His clinic research interests include cartilage and ligament disorders, using pediatric cadaveric tissue and surgical 3D simulations to develop surgeries and improve outcomes for procedures that avoid damage to growth plates. His research in cartilage disease and osteochondritis dissecans, along with the ROCK Multi-center Research Group was awarded the 2026 American Academy of Orthopedic Surgery (AAOS) highest research award, Improving Musculoskeletal Patient Care Through Outcomes Research (IMPACT)
He has years of experience with performance, quality improvement, value, and he worked extensively with the AAOS Quality/Clinical Practice Guideline Committees. He is one of the POSNA members to launch the POSNA Safe Surgery Program. He is a national quality leader in health care with interests in patient safety, risk reduction, and improving value in health care with clinician integration into supply chain and has won awards for patient quality improvement and value optimization projects. He serves as a medical director for supply chain at Stanford, and co-chairs the value based management and cost savings reinvestments program at Stanford Packard Childrens. He is an avid cyclist, trail runner, hiker, and spends as much time outside as possible, with his partner Lonnie and their children Beck and Cooper. -
Krishna Shenoy
Member, Bio-X
Current Research and Scholarly InterestsWe conduct neuroscience, neuroengineering and translational research to better understand how the brain controls movement, and to design medical systems to assist people with paralysis. These are referred to as brain-machine interfaces (BMIs), brain-computer interfaces (BCIs) and intra-cortical neural prostheses. We conduct this research as part of our Neural Prosthetic Systems Lab (NPSL) and our Neural Prosthetics Translational Lab (NPTL), which I co-direct with Prof. Jaimie Henderson, M.D.
-
Seth Lawrence Sherman, MD
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsMy research focuses on ways to augment tissue healing, improve human performance, and prevent musculoskeletal injuries. Approaching these challenges through parallel basic science and clinical pathways, our team works from the “bedside to the bench and back to the bedside”, identifying areas of clinical need to deliver evidence-based solutions for patients.
We collaborates with orthopaedic surgeons, non-surgical physicians, and researchers within bioengineering, human performance, and musculoskeletal imaging across the Stanford campus. The team is developing novel methods to accurately record human movement (including wearable technology, phone-based systems), rapid MRI imaging protocols, and exploring the use of biomarkers to track injury and recovery. This research builds on my earlier work, which utilized portable, inexpensive software for Microsoft Kinect to detect knee injury risk in youth athletes performing a drop vertical jump test. The team’s multifaceted goal is: 1) develop innovative methods to screen for injury risk (i.e. youth athlete non-contact ACL), 2) create targeted intervention programs to reduce risk, 3) enhance athletic performance; and 4) improve accuracy of return to play testing following injury/surgery (i.e. clinical evaluation, biomarkers, functional tests, imaging analysis for healing).
In the laboratory,our team investigates cellular and molecular deficiencies in tissue types including tendon, ligament, articular cartilage, and meniscus. By understanding aberrant pathways leading to tissue injury, they can identify innovative therapeutic targets for intervention. In collaboration with the Genetic Engineering and Synthetic Biology laboratories, Dr. Sherman’s research has explored the role of orthobiologic agents such as platelet rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) for tissue healing in patella tendinopathy (the breakdown of collagen in a tendon). Our lab is also investigating the use of CBD for musculoskeletal applications as an alternative to commonly used local anesthetics and cortisone derivatives. In my earlier work, we researched the cellular toxicity of such applications.
In addition to basic science research, I have helped to build a Sports Medicine clinical research team that includes several full-time clinical research coordinators, residents, fellows, and students. The team collects prospective outcomes on their patients using a novel data collection platform called Patient IQ. The group is part of the JUPITER study which is the largest, multicenter study ever assembled in patellofemoral instability. They are additionally planning to enroll in FDA-approved clinical studies investigating pioneering strategies for knee cartilage restoration, joint preservation, and orthobiologic injections for osteoarthritis. Recent clinical publications explore outcomes in meniscus preservation and transplantation, medial patellofemoral ligament reconstruction, osteochondral allograft and matrix-induced autologous chondrocyte implantation (MACI), and surgical augmentation using PRP/BMAC. The clinical research team actively reports results of non-surgical and surgical interventions to continue to introduce new knowledge to the field, with the goal of improved patient outcome. -
Sidhartha Sinha
Assistant Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsThere are two primary and overlapping emphases of my research, both of which are driven and united by needs-based innovation and translational potential:
(1) Understanding the microenvironment of the inflamed versus normal gut in order to identify better therapeutic targets for people with immune-¬mediated GI disorders. Here, our investigations include understanding the influence and interactions of pharmacologic and dietary interventions on gut microbiome/metabolomic changes and the host immune response. In the context of providing patients with new understanding and solutions for their disease, I have led and advised on the design of both pilot and large clinical trials (including new FDA approved therapies) for anti-inflammatory therapies;
(2) Applying novel approaches and technologies (including natural language processing, computer vision, and reinforcement learning) to identify and address unmet clinical needs. In this area we have ongoing and published efforts in my lab to validate and develop solutions to pressing clinical needs. We have developed/led new drug delivery technologies with a multidisciplinary team that have shown strong potential in ongoing human IBD clinical trials. My lab has utilized both supervised and unsupervised approaches to analyze social media discourse and unstructured data sets for identifying patient needs that are rarely addressed in clinical settings. We have gained insights into patient perceptions around preventative health interventions, such as health screening and diet, including the dearth of evidence-based dietary recommendations to treat IBD (despite strong patient desire for solutions in this domain). -
Matthew Smuck, MD
Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsI direct the Wearable Health Lab at Stanford, investigating medical applications of mobile technology to improve musculoskeletal and neurologic disease detection, treatment and prevention.
-
Michael Snyder, Ph.D.
Stanford W. Ascherman Professor of Genetics
Current Research and Scholarly InterestsOur laboratory use different omics approaches to study a) regulatory networks, b) intra- and inter-species variation which differs primarily at the level of regulatory information c) human health and disease. For the later we have established integrated Personal Omics Profiling (iPOP), an analysis that combines longitudinal analyses of genomic, transcriptomic, proteomic, metabolomic, DNA methylation, microbiome and autoantibody profiles to monitor healthy and disease states
-
Hyongsok Tom Soh
W. M. Keck Foundation Professor of Electrical Engineering, Professor of Radiology (Diagnostic Sciences Laboratory) and of Bioengineering
BioDr. Soh received his B.S. with a double major in Mechanical Engineering and Materials Science with Distinction from Cornell University and his Ph.D. in Electrical Engineering from Stanford University. From 1999 to 2003, Dr. Soh served as the technical manager of MEMS Device Research Group at Bell Laboratories and Agere Systems. He was a faculty member at UCSB before joining Stanford in 2015. His current research interests are in analytical biotechnology, especially in high-throughput screening, directed evolution, and integrated biosensors.
-
Ivan Soltesz
James R. Doty Professor of Neurosurgery and Neurosciences
BioIvan Soltesz received his doctorate in Budapest and conducted postdoctoral research at universities at Oxford, London, Stanford and Dallas. He established his laboratory at the University of California, Irvine, in 1995. He became full Professor in 2003, and served as department Chair from 2006 to July 2015. He returned to Stanford in 2015 as the James R. Doty Professor of Neurosurgery and Neurosciences at Stanford University School of Medicine. His major research interest is focused on neuronal microcircuits, network oscillations, cannabinoid signaling and the mechanistic bases of circuit dysfunction in epilepsy.
His laboratory employs a combination of closely integrated experimental and theoretical techniques, including closed-loop in vivo optogenetics, paired patch clamp recordings, in vivo electrophysiological recordings from identified interneurons in awake mice, 2-photon imaging, machine learning-aided 3D video analysis of behavior, video-EEG recordings, behavioral approaches, and large-scale computational modeling methods using supercomputers. He is the author of a book on GABAergic microcircuits (Diversity in the Neuronal Machine, Oxford University Press), and editor of a book on Computational Neuroscience in Epilepsy (Academic Press/Elsevier). He co-founded the first Gordon Research Conference on the Mechanisms of neuronal synchronization and epilepsy, and taught for five years in the Ion Channels Course at Cold Springs Harbor. He has over 30 years of research experience, with over 20 years as a faculty involved in the training of graduate students (total of 16, 6 of them MD/PhDs) and postdoctoral fellows (20), many of whom received fellowship awards, K99 grants, joined prestigious residency programs and became independent faculty. -
Leina'ala Song, MD
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Song is a double board-certified sports medicine physician with Stanford Health Care Orthopaedics and Sports Medicine. She is a clinical assistant professor in the Department of Orthopaedic Surgery at Stanford University School of Medicine. Dr. Song completed fellowship training in orthopaedics and sports medicine at the University of Washington School of Medicine in Seattle, Washington.
Dr. Song specializes in managing a wide range of sports and musculoskeletal injuries. She performs ultrasound-guided injections including corticosteroid, hyaluronic acid, and PRP. She is also skilled at using high-resolution ultrasound to perform other minimally invasive interventions, such as ultrasound guided percutaneous tenotomy. She is currently the primary team physician for numerous Division 1 athletic teams at Stanford University, including men’s volleyball, women’s volleyball, beach volleyball, lacrosse, open weight crew, light weight crew, softball, artistic swim, and sailing.
Dr. Song’s research interests include the long-term outcomes of percutaneous ultrasound-guided tenotomy, orthobiologics, and the health of the female athlete. She has taught sports medicine fellows as well as primary care residents. She has provided sideline coverage at multiple athletic events, as well as pre-participation screenings for professional teams such as the Seattle Seahawks and Seattle Seawolves. -
Justin L. Sonnenburg
Alex and Susie Algard Endowed Professor
Current Research and Scholarly InterestsThe goals of the Sonnenburg Lab research program are to (i) elucidate the basic mechanisms that underlie dynamics within the gut microbiota and (ii) devise and implement strategies to prevent and treat disease in humans via the gut microbiota. We investigate the principles that govern gut microbial community function and interaction with the host using a broad range of experimental approaches including studies of microbiomes in diverse human cohorts.
-
David Spiegel
Jack, Lulu and Sam Willson Professor of Medicine
Current Research and Scholarly InterestsDr. Spiegel's research program involves mind/body interactions, including cancer progression, the response to traumatic stress, and the effect of hypnosis on the perception of pain and anxiety.
-
Randall Stafford
Professor of Medicine (Stanford Prevention Research Center)
Current Research and Scholarly InterestsAs Director of the SPRC Program on Prevention Outcomes and Practices, my work focuses on cardiovascular disease treatment and prevention, the adoption of new technology and practices, and patterns of physician practice, particularly medication prescribing. Specific interests include measuring and improving the quality of outpatient care, disparities in health care by race, gender, age and socioeconomic status, and interventions to improve prevention outcomes.
-
Jeremy Stanek
Clinical Assistant Professor, Orthopaedic Surgery
BioDr. Jeremy Stanek is a sports medicine physiatrist who specializes in performing arts medicine, sports medicine, and musculoskeletal medicine. He enjoys treating musicians, dancers, athletes of all abilities, and anyone who wants to become or stay active. He performs diagnostic ultrasound as well as ultrasound-guided and fluoroscopic-guided procedures.
Dr. Stanek grew up on a small farm near the town of Qulin, Missouri. He received degrees in music performance from the University of Missouri and University of New Mexico and had a career as a professional trumpet player until developing focal dystonia (musicians' dystonia). Wanting to utilize his experience and education as a performer, he chose medicine as his next career. He graduated from the University of Missouri School of Medicine then completed his intern year at the Medical College of Wisconsin, followed by advanced residency training in physiatry (physical medicine & rehabilitation) at the University of Missouri. In 2018, Dr. Stanek completed a fellowship in sports medicine at Washington University in St. Louis, where he also was a provider in the Medical Program for Performing Artists, treating members of the St. Louis Ballet and his former colleagues in the St. Louis Symphony and community bands and orchestras. He has also provided coverage for a variety of events such as MMA fights, endurance sports events, and was a team physician for Washington University Athletics.
He conducts research in performing arts medicine and has given numerous conference presentations. Additionally, he enjoys speaking with professional and student musicians/dancers to educate them on arts medicine and avoiding injuries. In his free time, he enjoys working on old cars, baking, and participating in triathlons and other endurance sports. -
Claude Steele
Lucie Stern Professor in the Social Sciences, Emeritus
BioClaude M. Steele is an American social psychologist and a Professor of Psychology at Stanford University.
He is best known for his work on stereotype threat and its application to minority student academic performance. His earlier work dealt with research on the self (e.g., self-image, self- affirmation) as well as the role of self-regulation in addictive behaviors. In 2010, he released his book, Whistling Vivaldi and Other Clues to How Stereotypes Affect Us, summarizing years of research on stereotype threat and the underperformance of minority students in higher education.
He holds B.A. in Psychology from Hiram College, an M.A. in Social Psychology from Ohio State University, and a Ph.D. in Social Psychology and Statistical Psychology from Ohio State University.
He is elected to the American Academy of Arts and Sciences, the National Academy of Sciences, the National Science Board, the
National Academy of Education, and the American Philosophical Society.
He currently serves as a trustee of the Russell Sage Foundation and the John D. and Catherine T. MacArthur Foundation, and as a Fellow for both the American Institutes for Research and the American Academy of Political and Social Science.
He has served in several major academic leadership positions as the Executive Vice Chancellor and Provost at UC Berkeley, the I. James Quillen Dean for the School of Education at Stanford University, and as the 21st Provost of Columbia University. Past roles also include serving as the President of the Society for Personality and Social Psychology, as the President of the Western Psychological Association, and as a member of the Board of Directors of the American Psychological Society.
Professor Steele holds Honorary Doctorates from Yale University, Northwestern University, University of Chicago, University of Michigan, DePaul University and
Claremont Graduate University. -
Kristen K. Steenerson, MD
Clinical Associate Professor, Otolaryngology (Head and Neck Surgery)
Clinical Associate Professor, Adult NeurologyBioDr. Kristen K. Steenerson is a Clinical Associate Professor at Stanford University School of Medicine, specializing in vestibular neurology and neuro-otology. She directs clinical care within the Vestibular Neurology Clinic at the Stanford Ear Institute, where she focuses on the diagnosis and management of complex dizziness and vestibular disorders, including vestibular migraine, benign paroxysmal positional vertigo, Ménière disease, bilateral vestibulopathy, and persistent postural-perceptual dizziness.
Her academic program integrates translational research with clinician education to improve the diagnosis and treatment of vestibular disorders. Her research focuses on the development and validation of objective, technology-enabled tools to measure vestibular function in real-world settings. She leads initiatives evaluating wearable electro-oculography platforms for ambulatory nystagmus detection, as well as sensor-based systems using inertial measurement units to assess mobility, fall risk, and functional engagement. Her work leverages multidisciplinary collaboration across neurology, otolaryngology, audiology, engineering, and data science, with the goal of establishing scalable digital biomarkers and vestibular-specific clinical trial endpoints.
In parallel, Dr. Steenerson is deeply engaged in national and international clinician education. She serves as course director and faculty for multiple continuing medical education programs in vestibular neurology and neuro-otology, with a focus on bedside examination skills, acute dizziness evaluation, and diagnostic reasoning. She has developed interdisciplinary curricula and clinical training pathways designed to expand vestibular expertise among neurologists, otolaryngologists, advanced practice providers, and trainees.
Her scholarly work also includes clinical outcomes research and care delivery innovation, particularly in vestibular migraine and episodic vertigo disorders. She has led initiatives to standardize triage, referral pathways, and multidisciplinary care models for patients with dizziness, translating evidence into practical frameworks that improve access, diagnostic accuracy, and patient outcomes.
Through the integration of clinical innovation, translational research, and clinician education, Dr. Steenerson’s work aims to modernize vestibular care and expand the reach of specialized expertise beyond tertiary referral centers. -
Marcia L. Stefanick, Ph.D.
Professor (Research) of Medicine (Stanford Prevention Research Center), of Obstetrics and Gynecology and, by courtesy, of Epidemiology and Population Health
On Leave from 2026-07-16 To 2027-09-17Current Research and Scholarly InterestsMarcia L. Stefanick, Ph.D is a Professor of Medicine Professor of Obstetrics and Gynecology, and by courtesy, Professor of Epidemiology and Population Health at Stanford University School of Medicine. Dr. Stefanick’s research focuses on chronic disease prevention (particularly, heart disease, breast cancer, osteoporosis, and dementia) in both women and men. She is currently the Principal Investigator the Women’s Health Initiative (WHI) Extension Study, having been the PI of the Stanford Clinical Center of the landmark WHI Clinical Trials and Observational Study since 1994 and Chair of the WHI Steering and Executive Committees from 1998-2011, as well as PI of the WHI Strong and Healthy (WHISH) Trial which is testing the hypothesis that a DHHS-based physical activity intervention, being delivered to a multi-ethnic cohort of about 24,000 WHI participants across the U.S., aged 68-99 when the trial started in 2015, will reduce major cardiovascular events over 8 years, compared to an equal number of “usual activity” controls. Dr. Stefanick is also PI of the Osteoporotic Study of Men (MrOS) which is continuing to conduct clinical assessments of bone and body composition in survivors of an original cohort of nearly 6000 men aged 65 and over in 2001. As founding Director of the Stanford Women’s Health and Sex Differences in Medicine (WHSDM, “wisdom”) Center, she plays a major role in promoting research and teaching on Sex and Gender in Human Physiology and Disease, Women’s Health and Queer Health and Medicine. Dr. Stefanick also plays major leadership roles at the Stanford School of Medicine, including as co-leader of the Population Sciences Program of the Stanford Cancer Institute, Stanford’s NCI-funded comprehensive cancer center.
Dr. Stefanick obtained her B.A. in biology from the University of Pennsylvania, Philadelphia, PA (1974), then pursued her interest in hormone and sex difference research at the Oregon Regional Primate Research Center, after which she obtained her PhD in Physiology at Stanford University, focusing on reproductive physiology and neuroendocrinology, with exercise physiology as a secondary focus. Her commitment to human research led to a post-doctoral fellowship in Cardiovascular Disease Prevention at the Stanford Prevention Research Center, which has been her academic home for nearly 40 years. -
Lea Steffes
Assistant Professor of Pediatrics (Pulmonary Medicine)
BioDr. Steffes is a pediatric pulmonologist and Assistant Professor in Pediatrics in the Division of Pulmonary Medicine at Stanford University. She has completed an advanced fellowship in Pulmonary Vascular Disease at Lucile Packard Children's Hospital Stanford. Her clinical expertise focuses on rare pediatric lung diseases, with particular specialization in heritable forms of pulmonary vascular disease and developmental lung disorders.
Dr. Steffes' research centers on understanding the cellular characteristics of occlusive neointimal lesions, the abnormal cells that obstruct pulmonary blood flow in pulmonary hypertension. Her work specifically examines the contribution of mesenchymal cell subsets to pediatric pulmonary vascular disease, delineating mechanisms within both pre- and post-capillary networks. By leveraging insights from developing human and diseased mouse lung, her research provides a mechanistic framework for understanding childhood-onset pulmonary vascular diseases with the ultimate goal of identifying novel therapeutic targets for pulmonary hypertension.
